NCT01495260View on ClinicalTrials.gov

A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Adrenomyeloneuropathy
Interventions
DRUG

N-acetylcysteine

N-acetylcysteine, 800-2400 mg daily for 2 months

DRUG

lipoic acid

lipoic acid, 300-600 mg daily for 2 months

DRUG

vitamin E

vitamin E, 150-300 mg daily for 2 months

Trial Locations (1)

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
collaborator

Ministerio de Sanidad, Servicios Sociales e Igualdad

OTHER_GOV

collaborator

Fundacion Hesperia

OTHER

lead

Pujol, Aurora, M.D.

INDIV

NCT01495260 - A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants | Biotech Hunter | Biotech Hunter